Skip to main content
OpenTrials
Completed

NCT Number: NCT01696331

Text Messaging for Adherence in Adolescent Liver Transplant Recipients

Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lucile Packard Children's Hospital

Palo Alto, California, 94304, United States

About this study

Adolescent patients who received a liver transplant will be recruited to participate in receiving text message reminders for lab tests. They will be send de-identified messages according to their required lab schedule. The investigators will monitor their adherence to lab tests as well as medication and clinic visits. They will also have a questionnaire about their medical regimen before and at the end of the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient >12 years
  • Received liver transplant
  • Followed by Stanford Liver Transplant Team

Exclusion criteria

  • No personal cell phone

Treatment and study plan

Text message reminder

Behavioral

Sent TM reminder at beginning and end of each month that corresponded to required lab frequency. Patients were able to send autoresponses.

Primary outcomes

  1. Adherence to lab tests

    Time frame: One year

Secondary outcomes

  1. Texting responses

    Time frame: 1 year

    Correspondence between actual completion of tests versus reported

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Official study title

Impact of Text Messaging on Adherence in Adolescent Liver Transplant Patients

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Oct 1, 2012
Registry last updated
Apr 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.